Fundz

Wandercraft acquires Ekso Bionics for robotics synergy

PRIVATEOct 03, 2026

Acquiring Company

Wandercraft

Acquired Company

Ekso Bionics®

ParisSan RafaelManufacturingSoftwareManufacturingBiotechnologyHealth CareMedical Device

Description

Wandercraft has acquired Ekso Bionics, merging two competitors in the exoskeleton market. The acquisition, completed on October 1, aims to enhance rehabilitation systems across over 700 facilities worldwide. By bringing together their products, Wandercraft seeks to expand its network and clinical capabilities in American rehabilitation centers.

Company Information

Company

Wandercraft

Location

Paris, Ile-de-France, France

About

Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. In our world premiere clinical trials, persons with paraplegia walked human-like, autonomously and without crutches. The Wanderteam walks on the edge of robotics. We cooperate with world class university labs and medical centers in Europe and the US.

Fundz sees it the moment Wandercraft makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Eric
Likely contact at this company
••••••••@••••••••

See Eric's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Wandercraft's next move

Learn about Strategic plan

Frequently asked

Who acquired Ekso Bionics®?

Ekso Bionics® was acquired by Wandercraft, based in Paris. The deal was reported on October 3, 2026. Wandercraft ‘s job is to make wheelchair users walk again. We make real the promises of robotics by providing an ordinary life to extraordinary people. We have developed the first autonomous exo. Wandercraft is privately held and operates in Manufacturing.

When did Wandercraft acquire Ekso Bionics®?

Wandercraft's acquisition of Ekso Bionics® was reported on October 3, 2026. Wandercraft has acquired Ekso Bionics, merging two competitors in the exoskeleton market. The acquisition, completed on October 1, aims to enhance rehabilitation systems across over 700 facilities worldwide. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Ekso Bionics® do?

® Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance and mobility across medical and industrial applications. It is publicly traded (CHRN), operating in Manufacturing, and is based in San Rafael.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.